Health of the retina in the infant and the formulation and corresponding use method for the infant in order to promote the advancement of eyesight are disclosed. The said formulation does not contain the egg phosphatide, includes the lutein of approximately 50mcg/liter at least on the basis of dokosahekisaen acid and the form which is taken in that way, the fat, the protein, the carbohydrate, the vitamin and the mineral are included, the lutein (mcg) anti- dokosahekisaen acid (mg) weight ratio is approximately 10:1 from approximately 1:2. As for the said formulation it is thought that especially it is useful even in reduction of risk of the immature child retina symptom early in the birth.乳児における網膜の健康および視覚の発達を促進するための乳児用製剤および対応使用方法を開示する。該製剤は卵リン脂質を含有せず、ドコサヘキサエン酸およびそのまま摂取される形態に基づき少なくとも約50mcg/リットルのルテインを含む、脂肪、タンパク質、炭水化物、ビタミンおよびミネラルを含み、ルテイン(mcg)対ドコサヘキサエン酸(mg)の重量比は約1:2から約10:1である。該製剤は早期産児における未熟児網膜症のリスクの軽減にも特に有用だと考えられる。
